NTLA vs EDIT
NTLA 与 EDIT 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | NTLAINTELLIA THERAPEUTICS, INC. | EDITEditas Medicine, Inc. |
|---|---|---|
| 市值 | $1.50B | $258.47M |
| 市销率 | 22.2x | 6.4x |
| 营收同比增长 | 16.9% | 25.4% |
| 净利同比增长 | 20.5% | 32.5% |
| 息税前利润率 | -651.7% | -394.9% |
| 净资产收益率 | -66.5% | -3631.1% |
| 一年总回报 | -6.2% | +8.0% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:NTLA vs EDIT
| 指标 | NTLA | EDIT |
|---|---|---|
| 期末价值 | $4.9K | $880 |
| 总回报 | -51.3% | -91.2% |
| 年化收益 (CAGR) | -6.8% | -21.1% |
| 波动率 | 78.4% | 83.5% |
| 夏普比率 | 0.25 | 0.07 |
| 索提诺比率 | 0.37 | 0.11 |
| 最大回撤 | -96.5% | -98.9% |
基于 2574 个共同交易日,2016-05-06 → 2026-08-03 · 无风险利率 3.91%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)